Every few years, a handful of young companies attempt something so ambitious that, if it works, it changes how we power our homes, treat illness, build things, or compute. Most of them will fall short, because that’s how startups work. A few might quietly reshape the world.
This guide looks at five startups working on big problems in energy, robotics, medicine, and computing. You don’t need a technical or financial background to follow along. For each company, we’ll cover what it’s trying to do, what’s actually been achieved so far, and what could go wrong, because an honest “company to watch” article should include all three.
A few ground rules first:
- This is a curated selection, not a ranking. Thousands of promising startups exist, and I chose these five to show a range of fields.
- This isn’t investment advice. Being impressive and being a good investment are different things, and most startups fail.
- Details change fast. Funding amounts, timelines, and valuations shift constantly. The figures here reflect public reporting as of October 2026, so check current news before relying on any number.
How to Read a “Startups to Watch” List
Before meeting the companies, here are some habits that help you separate substance from buzz.
Money is not proof. Large funding rounds show that investors are confident, not that the technology works. Some of the best-funded startups in history have failed.
Look for milestones, not announcements. “We plan to” is weaker than “we built and tested.”
Ask what could go wrong. A trustworthy company, and a trustworthy article, can tell you the risks.
Remember the timeline problem. Ambitious technology almost always takes longer than first promised. Delays aren’t necessarily failure, but they’re worth noticing.
Watch the hype-to-evidence ratio. The bigger the claim, the more evidence you should want.
With that lens, here are the five.
1. Commonwealth Fusion Systems: Trying to Build a Star on Earth
Field: Clean energy
What it’s trying to do: Make fusion power practical
The big idea
Fusion is the process that powers the sun. It releases energy by fusing light atoms together, and it promises large amounts of electricity without the greenhouse gas emissions of fossil fuels and without the long-lived waste of today’s nuclear plants. Scientists have chased it for decades. The challenge is holding a gas hotter than the center of the sun in place long enough, and efficiently enough, to get more energy out than you put in.
Commonwealth Fusion Systems (CFS), a company that grew out of research at MIT, is betting on powerful magnets made from high-temperature superconductors. Stronger magnets allow a smaller, cheaper machine than older designs.
Where it stands
CFS is building a demonstration machine called SPARC in Massachusetts. The first of its 18 high-temperature superconducting magnets was installed in January 2026. SPARC is scheduled to begin operations in 2027, and the company projects it will produce far more fusion energy than it consumes, which would validate the design for ARC, a planned 400-megawatt power plant meant to feed the grid in the early 2030s. tecnobitsaps
The money has followed. CFS reportedly raised another $1 billion, bringing its total capital raised to $4 billion since its 2018 founding, and says its SPARC machine is about 80 percent complete. It is developing ARC in Chesterfield County, Virginia, with partners including Dominion Energy, Google, and Eni. groundground
What could go wrong
Building the machine is hard, but running it successfully is harder. Fusion has a long history of optimistic timelines that slipped. Even if SPARC works, turning it into an affordable, reliable power plant is a separate challenge, involving fuel supply, materials that survive intense conditions, regulation, and cost.
Why it’s worth watching
If SPARC hits its goals around 2027, it would be one of the most significant energy milestones in decades. Even a partial success would teach the field a great deal. Treat the 2027 results as the moment of truth.
2. Figure AI: Humanoid Robots Head for the Workplace
Field: Robotics and artificial intelligence
What it’s trying to do: Build general-purpose robots shaped like people
The big idea
Most robots today are specialists: an arm that welds, a machine that sorts packages. A humanoid robot is designed to work in spaces built for humans, using hands, walking on two legs, and eventually learning many different tasks. The appeal is flexibility. Instead of redesigning a factory for a robot, you’d bring in a robot that fits the factory.
Figure AI is one of the best-funded companies pursuing this idea. It combines robot hardware with AI software that lets the machine see, understand instructions, and decide how to move.
Where it stands
Figure raised more than $1 billion in a Series C round at a $39 billion valuation, saying the money would help scale its AI platform and its manufacturing line. That’s a remarkable number for a company founded only a few years ago. eenewseurope
There are early real-world signs, too. One report says a Figure 02 robot worked at a BMW plant in South Carolina for around 11 months, putting in ten-hour weekday shifts. That’s a meaningful step beyond a polished demo video, though details of what the robot actually did, and how much human help it needed, are important context that headlines often skip. st-hakky
What could go wrong
Skeptics point out that dexterity, reliability, and safety around people are extremely difficult, and that the gap between “works in a pilot” and “works every day for years at a competitive cost” can be enormous. Household robots, in particular, are far harder than factory ones because homes are messy and unpredictable. A $39 billion valuation also builds in sky-high expectations that any slowdown could puncture.
There’s an important social question too. If humanoids become practical, they’ll affect jobs, and communities will need to think about how that transition is handled.
Why it’s worth watching
Humanoids are a test of whether modern AI can control physical machines as impressively as it handles text. Watch for how many robots are actually deployed, how long they work without help, and what they cost, rather than for glossy videos.
3. Form Energy: Batteries That Last for Days
Field: Energy storage
What it’s trying to do: Store renewable power for several days, cheaply
The big idea
If you’ve read about batteries, you know today’s lithium-ion packs are great at storing a few hours of electricity. But a grid running heavily on wind and solar also needs to survive long stretches of cloudy, windless weather. That calls for multi-day storage.
Form Energy’s answer is the iron-air battery, which works on an idea you can picture easily. It uses reversible rusting: during discharge, iron reacts with oxygen from the air and turns into iron oxide, releasing electricity, and charging reverses the process. The ingredients are cheap and plentiful: iron, water, and air, instead of lithium, nickel, or cobalt. The batteries are designed to discharge for roughly 100 hours, just over four days. sacrasacra
Where it stands
Form Energy has moved from lab to factory. It raised $750 million in a Series G round, bringing its total equity funding above $2 billion, and says its commercial backlog grew from about 20 gigawatt-hours to 80 gigawatt-hours of battery systems. The money is meant to speed up manufacturing at its plant in Weirton, West Virginia. pulse2pulse2
The customers are interesting, too. Form signed a 12 gigawatt-hour supply agreement with an AI data center developer, and its batteries are part of a multi-technology deal involving Google and the utility Xcel Energy. That connects this story to a bigger one: AI’s hunger for electricity is creating demand for reliable power. energy-storage
What could go wrong
Iron-air batteries have a known trade-off. Their round-trip efficiency is considerably lower than lithium-ion’s, meaning more energy is lost between charging and discharging. The company has been upfront about this, arguing that very low cost and long duration make up for it. Whether that argument holds up in the real world depends on how the batteries perform at scale and how competitors, including other iron-air startups, advance. energy-storage
Why it’s worth watching
Cheap multi-day storage could be one of the missing pieces of a renewable grid. Watch for projects that are operating, not just signed, and for what they actually cost per unit of storage.
4. Isomorphic Labs: AI-Designed Medicine
Field: Healthcare and drug discovery
What it’s trying to do: Use AI to design new medicines faster
The big idea
Developing a new drug usually takes more than a decade and costs enormous sums, and many candidates fail. Isomorphic Labs, a company spun out of Google DeepMind, aims to use AI to design better drug candidates earlier in the process, so fewer fail later. The company grew from the same research lineage as AlphaFold, an AI system that predicts the 3D shapes of proteins, which is a key step in understanding how drugs interact with the body.
Where it stands
In May 2026, Isomorphic announced a $2.1 billion funding round led by Thrive Capital, with Alphabet and other investors participating. It also has partnerships with major pharmaceutical companies. arynews
But here’s where the honest part matters. The company now expects its first clinical trials by the end of 2026, a delay from the earlier goal of having AI-designed drugs in trials by the end of 2025. Its CEO later said he had been referring to pre-clinical work, which the company has already begun. In other words, as of this writing, no Isomorphic-designed drug is known to be in human testing yet. arynewsqz
What could go wrong
This is the sobering part of any AI-and-medicine story. Even a brilliantly designed molecule can fail in human trials because of safety problems or because it simply doesn’t work in real bodies. AI might speed up the early stages, but it can’t skip the years of testing that protect patients. So even good news here would arrive slowly.
Why it’s worth watching
The first human trial of an AI-designed drug will be a notable milestone, not because it proves success, but because it starts the real test. Over the coming years, the key question is whether AI-assisted drug design produces more successful medicines, not just faster early-stage results.
5. PsiQuantum: The Race to Build a Useful Quantum Computer
Field: Computing
What it’s trying to do: Build a large, error-corrected quantum computer
The big idea
Quantum computers use the strange rules of quantum physics to tackle certain problems that ordinary computers would take impractically long to solve. If they work at scale, they could help with designing new materials and drugs, optimizing complex systems, and more. Today’s quantum machines are small and error-prone, so the race is to build one big and reliable enough to be useful.
PsiQuantum uses particles of light (photons) and manufactures its chips using standard semiconductor methods, betting that this makes scaling up more realistic.
Where it stands
It’s among the best-funded quantum companies in the world. It has raised approximately $2.32 billion in total funding. It has also won major government backing and is building sites in Chicago and in Brisbane, Australia. In 2026, Victor Peng became interim CEO while co-founder Jeremy O’Brien moved to executive chairman. jaredwatkinsquantumzeitgeist
What could go wrong
This is the most speculative company on the list. One research summary notes that as of April 2026, PsiQuantum had not publicly demonstrated an operational quantum processor, and that its Brisbane facility had been delayed. The company’s approach depends on technical milestones that haven’t yet been shown publicly. It’s a high-risk, high-reward bet, and the public money involved has drawn controversy in Australia. jaredwatkins
Why it’s worth watching
If the approach works, the payoff could be enormous. If it doesn’t, it will still teach the industry a lot. Watch for independent, verifiable demonstrations rather than announcements.
The Five at a Glance
| Company | Field | The bet | Strongest evidence so far | Biggest open question |
|---|---|---|---|---|
| Commonwealth Fusion Systems | Fusion energy | Compact fusion with powerful magnets | Magnets being installed; SPARC well advanced | Will SPARC deliver net energy in 2027? |
| Figure AI | Humanoid robots | General-purpose robot workers | Reported factory deployment; huge funding | Can it be reliable, safe, and affordable at scale? |
| Form Energy | Grid storage | Multi-day iron-air batteries | Large backlog; factory operating | Efficiency and cost in real projects |
| Isomorphic Labs | AI drug discovery | Faster, better drug design | Big funding; pharma partnerships | Will AI-designed drugs succeed in humans? |
| PsiQuantum | Quantum computing | Photonic, manufacturable quantum computers | Large funding; government-backed sites | Can it demonstrate a working large-scale system? |
What These Five Have in Common
Look across these companies, and a few patterns stand out.
They’re attacking “hard tech” problems. These aren’t apps. They involve physics, chemistry, biology, and manufacturing. That means longer timelines and higher risks, but also potentially bigger payoffs.
AI is everywhere, and so is its energy appetite. Two of the five are directly AI-driven. A third, Form Energy, is partly serving AI’s power demands, and fusion is often discussed as a future power source for data centers.
They depend on enormous capital. Billions of dollars flowing into single companies is a sign of both confidence and a possible bubble. If investor enthusiasm cools, even good companies can struggle.
Timelines slip. Fusion, quantum, and AI drug trials have all seen schedules move. Treat deadlines as hopes rather than promises.
Real-world milestones matter more than valuations. The key moments ahead are concrete: SPARC’s first results, robots working actual shifts, batteries running on live grids, patients enrolled in trials, and a quantum machine demonstrated for independent experts.
Why the Big Numbers Should Make You Cautious
It’s tempting to be dazzled by billion-dollar valuations. A few reminders help.
A valuation is a price, not a result. It reflects what investors are willing to pay based on expectations.
Venture investing expects most bets to fail. Investors fund many startups knowing that a few big winners must make up for many losses. That works for professional funds, but it doesn’t mean each company is likely to succeed.
Early leaders aren’t guaranteed winners. Plenty of companies that led their category early were overtaken later, by competitors or by different technologies entirely.
Hype cycles are real. New technologies often go through waves of inflated expectations followed by disappointment, then slower, steadier progress. That can still end with transformation, as the internet showed.
If you’re thinking about investing in or working for a startup like these, treat it as a high-risk decision, do your own research, and consider speaking with a qualified financial professional. I can’t offer personal financial advice.
How You Can Follow Along (Without Becoming an Expert)
You don’t need to read technical papers to stay informed. Here are some friendly ways to keep up.
- Follow milestones, not headlines. Ask what physically happened: a machine switched on, a trial started, a system delivered.
- Read a mix of sources. Company announcements are useful but promotional. Add independent news coverage and expert commentary.
- Look for independent verification. Peer-reviewed research, third-party testing, and regulators’ approvals carry more weight than press releases.
- Notice who’s saying it. Founders and investors have understandable reasons to be optimistic.
- Check dates. In fast-moving fields, an article from a year ago may be out of date.
- Stay curious about the failures. A company’s setbacks often teach more than its successes.
What This Means for Everyday People
Even if you never invest a cent, these companies point to changes that could affect ordinary life.
Your electricity could change. Better storage and possibly fusion could make clean power more reliable, with effects on bills and outages.
Your workplace could change. If humanoid robots and AI systems mature, they’d reshape some jobs. Understanding the trend early helps you adapt your skills.
Your healthcare could change. Faster drug discovery might eventually mean new treatments sooner, though patients will still depend on careful testing.
Your technology could change. Quantum computing might eventually influence everything from materials science to security.
None of this is guaranteed or immediate. But knowing what’s coming helps you read the news with a clearer head and make better decisions about your skills, money, and attention.
Quick Glossary for Beginners
- Startup: A young company trying to grow quickly, often around a new technology or idea.
- Valuation: An estimate of what a company is worth, based on what investors pay for a share of it.
- Funding round (Series A, B, C…): Stages in which a startup raises money from investors.
- Fusion: Combining light atoms to release energy, the process that powers stars.
- Tokamak: A doughnut-shaped machine that uses magnets to contain superhot plasma for fusion.
- Humanoid robot: A robot built with a human-like body to work in human environments.
- Round-trip efficiency: How much of the energy you store in a battery you can get back out.
- Clinical trial: A carefully controlled test of a medicine in people.
- Qubit: The basic unit of information in a quantum computer.
- Hard tech: Technology that depends on difficult science and engineering, not just software.
The Bottom Line
The five companies in this guide are aiming at some of the biggest problems of the coming decade: clean power, flexible labor, better medicine, and a new kind of computing. Each has serious backing and real progress to point to. Each also faces hurdles that could slow or stop it, and none has yet delivered the world-changing result it’s aiming for.
That’s the healthiest way to follow them: with interest, patience, and a good dose of skepticism. Celebrate real milestones, question big promises, and remember that the most important breakthroughs often arrive later than predicted, and sometimes from places no one was watching.
If you take one habit from this article, make it this: whenever you hear about an exciting startup, ask, “What has actually been built and tested, and what is still just a plan?” That single question will take you further than any list of companies, including this one.